Reading time: 9 minutes Preeti Prangya Panda Cancer is the leading cause of mortality worldwide, with about 10 million deaths annually. Treatment outcomes are normally stage-sensitive, i.e., the sooner it is detected, the better the survival outcomes are for the patient. For instance, the current 5-year survival rate for stage I localized colorectal cancer is... Continue Reading →
Multiple Myeloma and Anemia: The Critical Connection
Reading Time: 3 mins Libby-Ann Harpaul-Sahadeo What is Multiple Myeloma? Multiple myeloma (MM) is a blood cancer that may sometimes present as tumors called plasmacytomas, which are clusters of these malignant plasma cells. In this disease, healthy plasma cells turn cancerous and multiply uncontrollably. The cancerous plasma cells also produce excessive amounts of an abnormal... Continue Reading →
Primary refractory and relapsed diffuse large B-cell lymphoma: current treatment options and ongoing developments, an activity
Reading time: 13 minutes (special: includes a pre- and post-article quiz activity!) Néstor Zumaya Image from: Bock AM, Narendranath Epperla. Therapeutic landscape of primary refractory and relapsed diffuse large B-cell lymphoma: Recent advances and emerging therapies. Journal of Hematology & Oncology. 2025 Jul 1;18(1). Activity: Choose the right answer based on your current knowledge. You’ll... Continue Reading →
Immunotherapies for Ovarian Cancer Treatment
Reading time: 7 minutes Lubna Najm Ovarian cancer is one of the top ten most common malignancies to affect women and females worldwide (NIH National Cancer Institute, 2025; Wang et al., 2025), with a 51.6% five-year survival rate (NIH National Cancer Institute, 2025). Named the ‘silent killer’ amongst women-prevalent diseases because its symptoms are either... Continue Reading →
